About This EventSionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing ...
Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show... On Tuesday, TD Cowen began coverage on Sionna Therapeutics (NASDAQ:SION) ...
Odyssey Therapeutics and Sionna Therapeutics have filed to carry out initial public offerings (IPOs) on the Nasdaq, taking the number in the newly-filed queue to four since the start of the year. The ...
Munster GAA chiefs on Monday announced funding of €1.3million for club capital development projects in the province.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results